Sunday, 10 March 2013

Sapporo Medical University set to launch stem cell trial for cerebral infarction

The Sapporo Medical University, Japan (SMU) announced that it will soon commence a clinical trial for the treatment of cerebral infarction. The patients will be given a stem cell therapy containing cultivated, autologous adult stem cells, extracted from bone marrow tissue.

According to the announcement, this will be the second trial conducted by the university. The first trial was launched by SMU researchers, led by Prof. Osamu Honmo, in 2007 and 12 patients had enrolled. Reportedly, all patients showed great motor improvement while more than 50% of them managed to fully return back to normal everyday activities.

CT scan slice of the brain showing a right-hemispheric cerebral infarct

During the new trial, the researchers plan to first extract stem cells from the patients' own bone marrow which will then be mass cultivated before being administered intravenously. If everything goes well, the treatment will lead to neural regeneration, and ultimately motor function improvement. 

The researchers hope that the stem cell treatment will be publicly available after about three years. 

Cerebral infarction is an ischemic stroke resulting from a disturbance in the blood vessels that supply blood to the brain.

Video about Cerebral infarction


No comments:

Post a Comment

Please note that we don't offer any kind of medical advice. Questions requesting specific medical advice (e.g. "where can I get this treatment", "will this cure XXX condition" etc) will be published but most probably ignored by the site's administrators. :)